CIViC
Compass
Tumors
Genes
Variants
Evidence
Assertions
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home
/
Biomarker
BRAF non-V600 — resistance to vemurafenib
Gene:
BRAF
· Type:
mutation
Indications: Melanoma
Sensitivity
Resistance
CIViC Context
FDA Sensitivity Assertions
No sensitivity assertions.